BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 31414920)

  • 1. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
    Bilsborrow JB; Doherty E; Tilstam PV; Bucala R
    Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
    Kim KW; Kim HR
    Korean J Intern Med; 2016 Jul; 31(4):634-42. PubMed ID: 27169879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.
    Leng L; Chen L; Fan J; Greven D; Arjona A; Du X; Austin D; Kashgarian M; Yin Z; Huang XR; Lan HY; Lolis E; Nikolic-Paterson D; Bucala R
    J Immunol; 2011 Jan; 186(1):527-38. PubMed ID: 21106847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE).
    Wallace DJ; Figueras F; Wegener WA; Goldenberg DM
    Ann Rheum Dis; 2021 Jul; 80(7):954-955. PubMed ID: 33619162
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
    Santos LL; Morand EF
    Clin Chim Acta; 2009 Jan; 399(1-2):1-7. PubMed ID: 18838066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
    Huang H; Chen D; Pu J; Yuan A; Fu Q; Li J; Leng L; Bucala R; Ye S; Lu L
    Int Immunopharmacol; 2019 Nov; 76():105874. PubMed ID: 31499270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
    Wang FF; Zhu LA; Zou YQ; Zheng H; Wilson A; Yang CD; Shen N; Wallace DJ; Weisman MH; Chen SL; Lu LJ
    Arthritis Res Ther; 2012 May; 14(3):R103. PubMed ID: 22551315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.
    Tilstam PV; Qi D; Leng L; Young L; Bucala R
    Expert Opin Ther Targets; 2017 Jul; 21(7):671-683. PubMed ID: 28562118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.
    Lapter S; Ben-David H; Sharabi A; Zinger H; Telerman A; Gordin M; Leng L; Bucala R; Shachar I; Mozes E
    Immunology; 2011 Jan; 132(1):87-95. PubMed ID: 20738420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
    Bloom J; Sun S; Al-Abed Y
    Expert Opin Ther Targets; 2016 Dec; 20(12):1463-1475. PubMed ID: 27762152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
    Bae SC; Lee YH
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):74-79. PubMed ID: 29096759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Ayoub S; Hickey MJ; Morand EF
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):98-105. PubMed ID: 18235539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor in rheumatoid arthritis.
    Morand EF; Leech M
    Front Biosci; 2005 Jan; 10():12-22. PubMed ID: 15576336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
    Santoscoy-Ascencio G; Baños-Hernández CJ; Navarro-Zarza JE; Hernández-Bello J; Bucala R; López-Quintero A; Valdés-Alvarado E; Parra-Rojas I; Illades-Aguiar B; Muñoz-Valle JF
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1037. PubMed ID: 31701681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
    Zhang Z; Zhang R; Li L; Zhu L; Gao S; Lu Q; Gu Y; Zhang Y; Yang H; Hou T; Zhen X; Zheng LT
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):149-157. PubMed ID: 29447014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
    Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.
    Llamas-Covarrubias MA; Valle Y; Bucala R; Navarro-Hernández RE; Palafox-Sánchez CA; Padilla-Gutiérrez JR; Parra-Rojas I; Bernard-Medina AG; Reyes-Castillo Z; Muñoz-Valle JF
    Cytokine; 2013 Mar; 61(3):759-65. PubMed ID: 23402792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
    Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y
    J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.
    Ochi A; Chen D; Schulte W; Leng L; Moeckel N; Piecychna M; Averdunk L; Stoppe C; Bucala R; Moeckel G
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F767-F780. PubMed ID: 28539339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.